Ghicl - Hôpital Saint-Vincent de Paul

Lille 59020

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Severe Alopecia Areata

Studies at this site

• A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata — Running, not enrolling
• A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis — Completed